Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2007
11/28/2007EP1858488A1 Tigecycline compositions and methods of preparation
11/28/2007EP1858484A1 Microemulsions of cannabinoid receptor binding compounds
11/28/2007EP1858482A2 Methods of reducing microbial contamination
11/28/2007EP1858481A1 Ophthalmologic compositions and use mode thereof
11/28/2007EP1858327A1 Use of 4-aminopyrimidines for the prevention of fungal pests novel 4-aminopyrimidines method for production thereof and agents comprising the same
11/28/2007EP1858326A1 Methods of treating gastrointestinal inflammation
11/28/2007EP1858325A2 Compounds for inhibiting beta-amyloid production and methods of identifying the compounds
11/28/2007EP1765356B1 Spray composition comprising a combination of calcitriol and clobetasol propionate, an alcoholic phase, at least one volatile silicone and one non volatile oily phase
11/28/2007EP1737862A4 Imidazopyridine compound
11/28/2007EP1735330B1 Progesterone receptor modulators
11/28/2007EP1725543B1 4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments
11/28/2007EP1723157B1 Amorphous forms of risedronate monosodium
11/28/2007EP1678177B1 Triaza-spiropiperidine derivatives for use as glyt-1 inhibitors in the treatment of neurological and neuropsychiatric disorders
11/28/2007EP1667975B1 A polymorphic form of 3-phenylsulfonyl-8-piperazin-1-yl-quinoline
11/28/2007EP1663978B1 Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
11/28/2007EP1654225A4 Melanin concentrating hormone receptor antagonists
11/28/2007EP1635851A4 Methods for treating cognitive impairment and improving cognition
11/28/2007EP1620403B1 Novel 3,4-disubstituted 1,2,3,6-tetrahydropyridine derivatives
11/28/2007EP1597302B1 Polymer guanidine derivatives as a cytostatic medicament
11/28/2007EP1592447B1 Devices and compositions containing boron and silicon for use in neutron capture therapy
11/28/2007EP1553909A4 Quick dissolve compositions and tablets based thereon
11/28/2007EP1534674A4 Cytotoxic agents containing novel potent taxanes and their therapeutic use
11/28/2007EP1494686A4 Oral rehydration composition
11/28/2007EP1458395B1 Medical use of gsk3-inhibiting oxindole derivatives
11/28/2007EP1448201B1 N-(indolcarbonyl-)piperazine derivatives for the treatment of obesity
11/28/2007EP1438041B1 Spermicides
11/28/2007EP1406613B1 Organic nitratederivatives for the treatment of atherosclerosis and vascular diseases
11/28/2007EP1399430B1 Oxazol/ thiazol-derivatives activators of the hppar-alpha receptor
11/28/2007EP1373257B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
11/28/2007EP1333832B1 Novel uses of combined 5-ht1a agonists and serotonin reuptake inhibitors
11/28/2007EP1315718B1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
11/28/2007EP1293507B1 Process for producing crystal
11/28/2007EP1284653B1 Infrared thermography and treatment of sexual dysfunctions
11/28/2007EP1261322B1 Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
11/28/2007EP1221997B1 System and device for preventing restenosis in body vessels
11/28/2007EP1006794B1 A method for treating or preventing alzheimer's disease
11/28/2007EP0983222B1 Pharmaceutical agents for the treatment of cerebral amyloidosis
11/28/2007EP0959682B1 Therapeutic applications of laminin and laminin-derived protein fragments
11/28/2007EP0910387B1 Apoptosis associated protein bbk
11/28/2007EP0879054B1 Application of pyrrolidine derivatives to the preparation of medicaments intended to the treatment of drug abuse
11/28/2007CN200980747Y Medicine releasing structure for medicine eluting apparatus
11/28/2007CN101080499A Genomic screen for epigenetically silenced tumor suppressor genes
11/28/2007CN101080413A Silicon compounds and their use
11/28/2007CN101080411A Thiazolopyridinone derivates as MCH receptor antagonists
11/28/2007CN101080408A Trycyclic heterocycles, their manufacture and use as pharmaceutical agents
11/28/2007CN101080407A Crystalline forms of a factor XA inhibitor
11/28/2007CN101080406A Indazole-carboxamide compounds
11/28/2007CN101080405A Quaternary ammonium salts as M3 antagonists
11/28/2007CN101080404A Pyrimidinylisoxazol derivative
11/28/2007CN101080403A Novel hydantoin derivatives as metalloproteinase inhibitors
11/28/2007CN101080402A Hydantoin derivatives useful as metalloproteinase inhibitors
11/28/2007CN101080401A Substituted biaryl analogues
11/28/2007CN101080398A Method for the production of oxazoles by condensing aromatic aldehydes with alpha-ketoximes to N-oxides and then reacting the same with activated acid derivatives
11/28/2007CN101080396A Quinoxalines as B Raf inhibitors
11/28/2007CN101080395A Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents
11/28/2007CN101080393A New (5's)-2',4'-dicyclopentyl -3'-9(s)-fluoro(4-(trifluoromethyl) phenyl)methyl)-5',8' -dihydro-6'h-spiro(cyclopropane-1,7'-quinoline)- 5'-ol is a cholesterol ester transfer protein inhibitor useful f
11/28/2007CN101080392A Piperazinyl pyridine derivatives as anti-obesity agents
11/28/2007CN101080388A Piperidinesulfonylureas and -thioureas, their preparation, their use and pharmaceutical compositions comprising them
11/28/2007CN101080385A Amine salts of (-)-2-((2-(4-hydroxyphenyl)ethyl)thio)-3-(4-(2-(4-((methylsulfonyl)oxy)phenoxy)ethyl)phenyl)propanoic acid
11/28/2007CN101080383A Tri (hydroxymethyl) methylamine salt or an ethanol amine salt of (2S) -2-ethoxy-3- (4-{2- [hexyl (2- phenylethyl) amino] - 2 -oxoethoxy} phenyl) propanoic acid
11/28/2007CN101080382A Hydroxybiphenyl carboxylic acids and derivatives, method for producing the same and their use
11/28/2007CN101080381A Manufacture process of n-substituted salicylamides
11/28/2007CN101080250A Methods of using fatty-acid esters of estrogens and thermogenic compounds for reducing the body weight of a mammal and compositions containing the same
11/28/2007CN101080234A Certain aminoalkyl glucosaminide phosphate compounds and their use
11/28/2007CN101080233A Methods of using fatty-acid esters of estrogens and serotonin reuptake inhibiting compounds for reducing the body weight of a mammal and compositions containing the same
11/28/2007CN101080232A Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and hmg CoA reductase inhibitors
11/28/2007CN101080231A Method for preparing galantamine hydrobromide
11/28/2007CN101080230A Treatment and control of severe infections including cystic fibrosis
11/28/2007CN101080229A Substituted purinyl derivatives with immunomodulator and chemoprotective activity and use alone or with medium-chain length fatty acids or glycerides
11/28/2007CN101080228A Piperazinyl-pyridine analogues
11/28/2007CN101080227A Combinations of therapeutic agents for treating cancer
11/28/2007CN101080226A Amido compounds and their use as pharmaceuticals
11/28/2007CN101080225A Combination therapy comprising telmisartan and hydrochlorothiazide
11/28/2007CN101080224A Methods and compositions for treating pain
11/28/2007CN101080223A Formulations of suberoylanilide hydroxamic acid and methods for producing same
11/28/2007CN101080222A Chemically stable compositions of 4-hydroxy tamoxifen
11/28/2007CN101080221A Parenteral combination therpy for infective conditions with drug resistant bacterium
11/28/2007CN101080219A External patches containing etofenamate
11/28/2007CN101080216A Compositions comprising polymeric emulsifiers and methods of using same
11/28/2007CN101080168A Process for making antimicrobial polymer articles
11/28/2007CN101078716A Biomarker for response monitoring of CDK inhibitors in the clinic
11/28/2007CN101078012A 干细胞分化 Stem cell differentiation
11/28/2007CN101077891A Sepia polysaccharide sulfated derivative and preparing method thereof
11/28/2007CN101077883A Small interference RNA sequence of hepatitis B virus gene and preparation method thereof
11/28/2007CN101077881A 1-O-beta-D-glucopyranosylgeraniol-10,5-olide and use thereof
11/28/2007CN101077875A Boronic ester and acid compounds, synthesis and uses
11/28/2007CN101077873A Novel NEO-clerodane type diterpene compound and application thereof
11/28/2007CN101077869A Crystalline 1-methylcarbapenem compound
11/28/2007CN101077868A Thiadiazoles substituted imidazoles anti-anaerobe compounds
11/28/2007CN101077866A Substituted benzoxazoles antifungal compounds and preparation method thereof
11/28/2007CN101077865A Phthalazines derivatives, preparation method thereof, medicament composition and use
11/28/2007CN101077862A D-glucose-L-amino acid, preparation method and application thereof
11/28/2007CN101077858A Method for preparing butenafine hydrochloride
11/28/2007CN101077852A Preparation for chemical component of Shenmai injection and application of the same in curing cardio-cerebrovascular disease
11/28/2007CN101077418A Bacteria nano magnetosome loaded with primary amino medicine and preparation method thereof
11/28/2007CN101077399A Process for producing traditional Chinese medicine 'naolijing'
11/28/2007CN101077392A Medicinal composition for treating chronic rhinitis and preparation method thereof
11/28/2007CN101077377A Compound chitosan iodide film coating agent for preventing and controlling mammitis of cow and sheep
11/28/2007CN101077374A Traditional Chinese medicine for preventing and treating metabolism syndrome
11/28/2007CN101077361A External applied Traditional Chinese medicine powder medicine for dewatering, anti-inflammation and pain-relieving
1 ... 3485 3486 3487 3488 3489 3490 3491 3492 3493 3494 3495 3496 3497 3498 3499 3500 3501 3502 3503 3504 3505 ... 7860